Literature DB >> 23617588

Immunology of neuromyelitis optica: a T cell-B cell collaboration.

Meike Mitsdoerffer1, Vijay Kuchroo, Thomas Korn.   

Abstract

Neuromyelitis optica (NMO) is a debilitating autoimmune inflammatory disease of the central nervous system (CNS) that is distinct from multiple sclerosis (MS). The discovery of NMO-immunoglobulin G (IgG) in the serum of NMO-but not MS-patients was a breakthrough in defining diagnostic criteria for NMO. NMO-IgG is an antibody directed against the astrocytic water channel protein aquaporin-4 (AQP4). While there is evidence that NMO-IgG is also involved in mediating tissue damage in the CNS, many aspects of the pathogenic cascade in NMO remain to be determined. It is clear that antigen-specific T cells contribute to the generation of NMO-IgG in the peripheral immune compartment, as well as to the development of NMO lesions in the CNS. T helper 17 (Th17) cells, equipped both in providing B cell help and inducing tissue inflammation, may be involved in NMO development and pathogenesis. Here, we review immunologic aspects of NMO, placing recent findings in the biology of T-B cell cooperation into perspective with autoimmunity of the CNS.
© 2013 New York Academy of Sciences.

Entities:  

Mesh:

Year:  2013        PMID: 23617588      PMCID: PMC3963833          DOI: 10.1111/nyas.12118

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  93 in total

1.  Aquaporin-4 expression is increased in oedematous human brain tumours.

Authors:  S Saadoun; M C Papadopoulos; D C Davies; S Krishna; B A Bell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

2.  Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes.

Authors:  Shannon R Hinson; Michael F Romero; Bogdan F Gh Popescu; Claudia F Lucchinetti; James P Fryer; Hartwig Wolburg; Petra Fallier-Becker; Susan Noell; Vanda A Lennon
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-29       Impact factor: 11.205

3.  Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation.

Authors:  Gurumoorthy Krishnamoorthy; Hans Lassmann; Hartmut Wekerle; Andreas Holz
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

Review 4.  The role of aquaporin-4 in the blood-brain barrier development and integrity: studies in animal and cell culture models.

Authors:  G P Nicchia; B Nico; L M A Camassa; M G Mola; N Loh; R Dermietzel; D C Spray; M Svelto; A Frigeri
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

5.  Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica.

Authors:  S Watanabe; I Nakashima; T Misu; I Miyazawa; Y Shiga; K Fujihara; Y Itoyama
Journal:  Mult Scler       Date:  2007-01       Impact factor: 6.312

6.  Devic's neuromyelitis optica: a clinicopathological study of 8 patients.

Authors:  R N Mandler; L E Davis; D R Jeffery; M Kornfeld
Journal:  Ann Neurol       Date:  1993-08       Impact factor: 10.422

7.  Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica.

Authors:  B Weinstock-Guttman; C Miller; Ea Yeh; M Stosic; M Umhauer; N Batra; F Munschauer; R Zivadinov; M Ramanathan
Journal:  Mult Scler       Date:  2008-06-23       Impact factor: 6.312

8.  Neuromyelitis optica: Passive transfer to rats by human immunoglobulin.

Authors:  Makoto Kinoshita; Yuji Nakatsuji; Takashi Kimura; Masayuki Moriya; Kazushiro Takata; Tatsusada Okuno; Atsushi Kumanogoh; Koji Kajiyama; Hiroo Yoshikawa; Saburo Sakoda
Journal:  Biochem Biophys Res Commun       Date:  2009-06-21       Impact factor: 3.575

9.  Pathogenic T cell responses against aquaporin 4.

Authors:  Maria Pohl; Marie-Therese Fischer; Simone Mader; Kathrin Schanda; Maja Kitic; Rakhi Sharma; Isabella Wimmer; Tatsuro Misu; Kazuo Fujihara; Markus Reindl; Hans Lassmann; Monika Bradl
Journal:  Acta Neuropathol       Date:  2011-04-06       Impact factor: 17.088

10.  IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.

Authors:  Vanda A Lennon; Thomas J Kryzer; Sean J Pittock; A S Verkman; Shannon R Hinson
Journal:  J Exp Med       Date:  2005-08-08       Impact factor: 14.307

View more
  31 in total

Review 1.  Monoclonal antibodies in treatment of multiple sclerosis.

Authors:  P S Rommer; A Dudesek; O Stüve; U K Zettl
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

2.  Comprehensive analysis of patients with neuromyelitis optica spectrum disorder (NMOSD) combined with chronic hepatitis B (CHB) infection and seropositive for anti-aquaporin-4 antibody.

Authors:  Jia Liu; Li Xu; Zhuo-Lin Chen; Min Li; Huan Yi; Fu-Hua Peng
Journal:  Bosn J Basic Med Sci       Date:  2018-02-20       Impact factor: 3.363

Review 3.  Inflammation in neurodegenerative diseases--an update.

Authors:  Sandra Amor; Laura A N Peferoen; Daphne Y S Vogel; Marjolein Breur; Paul van der Valk; David Baker; Johannes M van Noort
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

4.  Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production.

Authors:  Elizabeth Cotzomi; Panos Stathopoulos; Casey S Lee; Alanna M Ritchie; John N Soltys; Fabien R Delmotte; Tyler Oe; Joel Sng; Ruoyi Jiang; Anthony K Ma; Jason A Vander Heiden; Steven H Kleinstein; Michael Levy; Jeffrey L Bennett; Eric Meffre; Kevin C O'Connor
Journal:  Brain       Date:  2019-06-01       Impact factor: 13.501

Review 5.  Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders.

Authors:  Ingo Kleiter; Ralf Gold
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

6.  Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study.

Authors:  Ilya Ayzenberg; Joanna Schöllhammer; Robert Hoepner; Kerstin Hellwig; Marius Ringelstein; Orhan Aktas; Tania Kümpfel; Markus Krumbholz; Corinna Trebst; Friedemann Paul; Florence Pache; Mark Obermann; Lena Zeltner; Matthias Schwab; Achim Berthele; Sven Jarius; Ingo Kleiter
Journal:  J Neurol       Date:  2016-01-25       Impact factor: 4.849

7.  The IL-10-producing regulatory B cells (B10 cells) and regulatory T cell subsets in neuromyelitis optica spectrum disorder.

Authors:  Eun Bin Cho; Hye-Jin Cho; Jin Myoung Seok; Ju-Hong Min; Eun-Suk Kang; Byoung Joon Kim
Journal:  Neurol Sci       Date:  2018-01-19       Impact factor: 3.307

Review 8.  Targeting Neuromyelitis Optica Pathogenesis: Results from Randomized Controlled Trials of Biologics.

Authors:  Laura Cacciaguerra; Paola Tortorella; Maria A Rocca; Massimo Filippi
Journal:  Neurotherapeutics       Date:  2021-04-28       Impact factor: 6.088

9.  Low levels of vitamin D in neuromyelitis optica spectrum disorder: association with disease disability.

Authors:  Ju-Hong Min; Patrick Waters; Angela Vincent; Hye-Jin Cho; Byung-Euk Joo; Sook-Young Woo; Soo-Youn Lee; Hee-Young Shin; Kwang Ho Lee; Byoung Joon Kim
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

Review 10.  Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications.

Authors:  Giordani Rodrigues Dos Passos; Douglas Kazutoshi Sato; Jefferson Becker; Kazuo Fujihara
Journal:  Mediators Inflamm       Date:  2016-01-28       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.